- Sofosbuvir (SOF; Sovaldi)-based regimens are safe and effective for HCV/HIV-coinfected patients who are liver transplant (LT) candidates or recipients.
- When combined with an NS5A inhibitor, clearance rates topped 90%.
Why this matters
- Pre-LT therapy should be considered for HI...
You’ve reached the visitor articles limit
reserved for healthcare professionals
Already have an account? Login now